Therasense sharply reduced viable claims by requiring but-for materiality, meaning the Office would not have allowed the claim had it known, and by eliminating the sliding scale that permitted inferring intent from high materiality. Both elements now require independent proof. The defense retains value where established because it renders the entire patent unenforceable and supports an exceptional case fee award.